1. Differential expression of novel immunological biomarkers in TILS is associated with improved outcome in advanced triple negative breast cancer resistant to neoadjuvant chemotherapy. (March 2019) Authors: Cabioglu, N.; Onder, S.; Oner, G.; Karatay, H.; Özkurt, E.; CanTrablus, D.; Tukenmez, M.; Muslumanoglu, M.; Saip, P.; Yavuz, E. Journal: Breast Issue: Volume 44(2019)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗